Compare Crescent Energy Company Class A Common Stock (CRGY) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Crescent Energy Company Class A Common Stock trades at $12.83 (market cap $4.30B), while Relay Therapeutics Inc. Common Stock trades at $18.31 (market cap $3.82B). The key difference: Crescent Energy Company Class A Common Stock and Relay Therapeutics Inc. Common Stock are close in size by market cap, and Crescent Energy Company Class A Common Stock pays a 3.69% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| CRGY | RLAY | |
|---|---|---|
Market Cap | $4.30B | $3.82B |
Volume | 15,201,625 | 4,332,079 |
Sector | Energy | Health |
52-Week High | $15.37 | $20.75 |
52-Week Low | $7.75 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.31B | $2.93B |
Dividend Yield | 3.69% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
